Up to 50% of cancer patients suffer from a progressive atrophy of adipose tissue and
skeletal muscle, called cachexia, resulting in weight loss, a reduced quality of life, and a …

Loss of body weight in cancer patients strongly influences morbidity and mortality. Recent
studies have suggested that both tumor and host factors play a major role in tissue …

Progressive wasting is common in many types of cancer and is one of the most important
factors leading to the early death of cancer patients. Although anorexia frequently …

Background. Cancer cachexia encompasses a wide range of metabolic, hormonal, and
cytokine‐related abnormalities that result in a wasting syndrome possibly accounting for up …

Cancer cachexia is a complex multifactorial syndrome marked by a continuous depletion of
skeletal muscle mass associated, in some cases, with a reduction in fat mass. It is …

Advanced cancer patients exhibit cachexia, a condition characterized by a significant
reduction in the body weight predominantly from loss of skeletal muscle and adipose tissue …

Cancer cachexia is a complex syndrome that includes host tissue wasting, anorexia,
asthenia, and abnormal host intermediary metabolism. It is present in approximately 50% of …

Cancer cachexia is a devastating, multifactorial and often irreversible syndrome that affects
around 50–80% of cancer patients, depending on the tumour type, and that leads to …

Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …

Causative factors Nutritional supplementation or pharmacological manipulation of appetite
are unable to control the muscle atrophy seen in cancer cachexia. This suggests that tumour …